90 related articles for article (PubMed ID: 11185745)
1. Haplotype analysis suggests that the two predominant mutations in Japanese patients with holocarboxylase synthetase deficiency are founder mutations.
Yang X; Aoki Y; Li X; Sakamoto O; Hiratsuka M; Gibson KM; Kure S; Narisawa K; Matsubara Y; Suzuki Y
J Hum Genet; 2000; 45(6):358-62. PubMed ID: 11185745
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the holocarboxylase synthetase gene HLCS.
Suzuki Y; Yang X; Aoki Y; Kure S; Matsubara Y
Hum Mutat; 2005 Oct; 26(4):285-90. PubMed ID: 16134170
[TBL] [Abstract][Full Text] [Related]
3. Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency.
Yang X; Aoki Y; Li X; Sakamoto O; Hiratsuka M; Kure S; Taheri S; Christensen E; Inui K; Kubota M; Ohira M; Ohki M; Kudoh J; Kawasaki K; Shibuya K; Shintani A; Asakawa S; Minoshima S; Shimizu N; Narisawa K; Matsubara Y; Suzuki Y
Hum Genet; 2001 Nov; 109(5):526-34. PubMed ID: 11735028
[TBL] [Abstract][Full Text] [Related]
4. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population.
Yagasaki H; Oda T; Adachi D; Nakajima T; Nakahata T; Asano S; Yamashita T
Hum Mutat; 2003 May; 21(5):555. PubMed ID: 12673805
[TBL] [Abstract][Full Text] [Related]
5. Holocarboxylase synthetase deficiency: report of one case.
Chou IC; Wang CS; Lin WD; Lin HC; Tsai CH; Wang TR; Tsai FJ
Acta Paediatr Taiwan; 2006; 47(6):309-11. PubMed ID: 17407983
[TBL] [Abstract][Full Text] [Related]
6. Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency.
Morrone A; Malvagia S; Donati MA; Funghini S; Ciani F; Pela I; Boneh A; Peters H; Pasquini E; Zammarchi E
Am J Med Genet; 2002 Jul; 111(1):10-8. PubMed ID: 12124727
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment and gene mutation analysis in children with holocarboxylase synthetas deficiency].
Wang T; Ye J; Han LS; Qiu WJ; Zhang HW; Zhang YF; Gao XL; Wang Y; Gu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):609-12. PubMed ID: 19695181
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6.
Miksch S; Lumsden A; Guenther UP; Foernzler D; Christen-Zäch S; Daugherty C; Ramesar RK; Lebwohl M; Hohl D; Neldner KH; Lindpaintner K; Richards RI; Struk B
Hum Mutat; 2005 Sep; 26(3):235-48. PubMed ID: 16086317
[TBL] [Abstract][Full Text] [Related]
10. Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in Taiwan: implications for low prevalence and founder mutations of Taiwanese myotonic dystrophy type 1.
Pan H; Lin HM; Ku WY; Li TC; Li SY; Lin CC; Hsiao KM
Eur J Hum Genet; 2001 Aug; 9(8):638-41. PubMed ID: 11528511
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of the p.R277X/p.R1511X compound heterozygous mutation in the thyroglobulin gene in unrelated families with congenital goiter and hypothyroidism: haplotype analysis using intragenic thyroglobulin polymorphisms.
Caputo M; Rivolta CM; Gutnisky VJ; Gruñeiro-Papendieck L; Chiesa A; Medeiros-Neto G; González-Sarmiento R; Targovnik HM
J Endocrinol; 2007 Oct; 195(1):167-77. PubMed ID: 17911408
[TBL] [Abstract][Full Text] [Related]
12. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients.
Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270
[TBL] [Abstract][Full Text] [Related]
13. Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Horinishi A; Okubo M; Tang NL; Hui J; To KF; Mabuchi T; Okada T; Mabuchi H; Murase T
J Hum Genet; 2002; 47(2):55-9. PubMed ID: 11924557
[TBL] [Abstract][Full Text] [Related]
14. Holocarboxylase synthetase deficiency: novel clinical and molecular findings.
Tammachote R; Janklat S; Tongkobpetch S; Suphapeetiporn K; Shotelersuk V
Clin Genet; 2010 Jul; 78(1):88-93. PubMed ID: 20095979
[TBL] [Abstract][Full Text] [Related]
15. [Cloning of the holocarboxylase synthetase cDNA and identification of mutations prevalent in Japanese HCS-deficient patients].
Narisawa K; Suzuki Y; Aoki Y
Nihon Rinsho; 1996 Jan; 54(1):259-67. PubMed ID: 8587199
[TBL] [Abstract][Full Text] [Related]
16. Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway.
Pigg M; Gedde-Dahl T; Cox D; Hausser I; Anton-Lamprecht I; Dahl N
Eur J Hum Genet; 1998; 6(6):589-96. PubMed ID: 9887377
[TBL] [Abstract][Full Text] [Related]
17. MYOC gene mutations in Spanish patients with autosomal dominant primary open-angle glaucoma: a founder effect in southeast Spain.
Campos-Mollo E; Sánchez-Sánchez F; López-Garrido MP; López-Sánchez E; López-Martínez F; Escribano J
Mol Vis; 2007 Sep; 13():1666-73. PubMed ID: 17893668
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy.
Aldave AJ; Yellore VS; Thonar EJ; Udar N; Warren JF; Yoon MK; Cohen EJ; Rapuano CJ; Laibson PR; Margolis TP; Small K
Am J Ophthalmol; 2004 Mar; 137(3):465-73. PubMed ID: 15013869
[TBL] [Abstract][Full Text] [Related]
19. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
Bergman A; Einbeigi Z; Olofsson U; Taib Z; Wallgren A; Karlsson P; Wahlström J; Martinsson T; Nordling M
Eur J Hum Genet; 2001 Oct; 9(10):787-93. PubMed ID: 11781691
[TBL] [Abstract][Full Text] [Related]
20. Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.
González S; Blanco I; Campos O; Julià M; Reyes J; Llompart A; Cabeza E; Germà JR; Obrador A; Capellá G
Cancer Genet Cytogenet; 2005 Apr; 158(1):70-4. PubMed ID: 15771908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
